Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

GlaxoSmitKline's headquarters

GSK joins new NHS innovation initiative

December 22, 2009
BMW, BT, GSK, HIEC, NHS

GlaxoSmithKline, as well as less obvious names such as BMW and BT, are among the companies involved in the NHS’s …

PDS appoints Paul Butler and Martin Slade

December 22, 2009
Manufacturing and Production PDS, Pharmaceutical Development Services, appointment, manufacturing and production

Pharmaceutical Development Services Ltd (PDS) has expanded its API (Active Pharmaceutical Ingredient) auditing capability, appointing two new associates. Paul Butler …

US healthcare reform demonstrators

US health reform heads for decisive vote

December 22, 2009
Sales and Marketing Obama, Senate, US healthcare

The US Senate has passed new healthcare legislation, giving President Barack Obama signs of progress on reform in both parliamentary …

Contract research news in brief

December 22, 2009
Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …

Sanofi-Aventis manufacturing facility in Dagenham

Sanofi pulls out of Dagenham

December 21, 2009
Manufacturing and Production Essex, Sanofi, closure

The UK stands to lose one of its flagship pharmaceutical manufacturing facilities with the recent announcement that Sanofi-Aventis’ site in …

Sanofi’s Plavix combination recommended for European approval

December 21, 2009
Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …

Roche's entry on Google sidewiki

Digital Pharma: Roche tackles sidewiki

December 21, 2009
Medical Communications Roche, digi, digital pharma, google, sidewiki

Roche has become the second pharma company to tackle sidewiki on its corporate website, posting an entry that sets out …

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009
Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …

Merck & Co building

Merck buys Avecia to boost biomanufacturing

December 21, 2009
Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …

Time-sensitive shipments go further

December 18, 2009
Manufacturing and Production

The logistical challenges of transporting clinical trials samples over long distances arerapidly being overcome, says Sue Lee, Manager of Biopharm …

Chiltern Announces Collaboration with Dr Nawab Qizilbash

December 18, 2009
Research and Development

Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …

BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009
Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …

UK supports stem cell research with online toolkit

December 18, 2009
Research and Development ReNeuron, regenerative medicine, stell cell

A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …

Sir-Liam-Donaldson

Sir Liam Donaldson steps down as England’s chief medical officer

December 18, 2009
Liam Donaldson, NHS, UK, appointment

England’s chief medical officer Sir Liam Donaldson will step down in May 2010 after 12 years of service. Details for …

InternetHands

ScopeMedical boosts digital offering

December 18, 2009
Medical Communications ScopeMedical, digi

Kent-based med ed agency ScopeMedical has boosted its in-house digital offering and says there are plans to grow it further …

Chris Begley

Hospira buys Orchid generic injectables business for $400m

December 18, 2009
Manufacturing and Production Hospira, India, Orchid, injectables

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …

NICElr

NICE still saying ‘no’ to Roche’s RoActemra

December 17, 2009
Sales and Marketing NICE, RoActemra, Roche

Roche will have to present a stronger case for arthritis drug RoActemra in order to gain approval, according to NICE. …

ICON headquarters

ICON investments will come to fruition in 2010

December 16, 2009
Research and Development ICON, Manchester, translational

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …

Blog footer

Digital Pharma: A Year in Digital (5/5)

December 16, 2009
Medical Communications 2009, Boehringer, digi, digital pharma, year in review

Favourite use of digital (pharma)• Microsoft’s future of healthcare video. It’s their vision of the possibilities that I fell in …

The Gateway to Local Adoption Series

Latest content